Furthermore, Sikder MOF et al. [27] demonstrated that the tumor-associated up-regulation of SLC6A14 was likely to be driven by Wnt signaling by activating the downstream mediator TCF4/β-catenin. The gene discussed is SLC6A14; the disease is neoplasm.